-
1
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
Pedersen TR, Kjekshus J, Berg K, et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
Pedersen, T.R.1
Kjekshus, J.2
Berg, K.3
-
2
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
-
Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-1307.
-
(1995)
N Engl J Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
-
3
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators
-
Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001-1009.
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
-
4
-
-
0032487931
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
-
Tonkin A, Aylward P, Colquhoun D, et al. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998; 339: 1349-1357.
-
(1998)
N Engl J Med
, vol.339
, pp. 1349-1357
-
-
Tonkin, A.1
Aylward, P.2
Colquhoun, D.3
-
5
-
-
0037031061
-
MRC/BHF Heart Protection Study of cholesterol lowering with sinivastatin in 20536 high-risk individuals: A randomized placebo-controlled trial
-
Heart Protection Study Group
-
Heart Protection Study Group. MRC/BHF Heart Protection Study of cholesterol lowering with sinivastatin in 20536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002; 360: 7-22.
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
6
-
-
0037420492
-
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): A multicentre randomized controlled trial
-
Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized controlled trial. Lancet 2003; 361: 1149-1158.
-
(2003)
Lancet
, vol.361
, pp. 1149-1158
-
-
Sever, P.S.1
Dahlof, B.2
Poulter, N.R.3
-
7
-
-
0003491942
-
-
Scottish Intercollegiate Guidelines Network, SIGN publication No 40. Edinburgh: Royal College of Physicians
-
Scottish Intercollegiate Guidelines Network. Lipids and the primary prevention of coronary heart disease. SIGN publication No 40. Edinburgh: Royal College of Physicians.
-
Lipids and the primary prevention of coronary heart disease
-
-
-
8
-
-
0032437504
-
Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association
-
Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association. Heart 1998; 80: S1-S29.
-
(1998)
Heart
, vol.80
-
-
-
10
-
-
1542432170
-
Guidelines for management of hypertension: Report of the fourth working party of the British Hypertension Society, 2004 - BHS IV
-
Williams B, Poulter NP, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004 - BHS IV. J Hum Hypertens 2004; 18: 139-185.
-
(2004)
J Hum Hypertens
, vol.18
, pp. 139-185
-
-
Williams, B.1
Poulter, N.P.2
Brown, M.J.3
-
11
-
-
0037193808
-
Resource management in prevention of coronary heart disease: Optimising prescription of lipid-lowering drugs
-
Shepherd J. Resource management in prevention of coronary heart disease: optimising prescription of lipid-lowering drugs. Lancet 2002; 359: 2271-2273.
-
(2002)
Lancet
, vol.359
, pp. 2271-2273
-
-
Shepherd, J.1
-
12
-
-
84889436895
-
The Tayside Medicines Monitoring Unit (MEMO)
-
4th edn, Strom BL ed, John Wiley and Sons: Chichester
-
Wei L, Parkinson J, MacDonald TM. The Tayside Medicines Monitoring Unit (MEMO). In Pharmacoepidemiology, 4th edn, Strom BL (ed.). John Wiley and Sons: Chichester, 2005; 323-336.
-
(2005)
Pharmacoepidemiology
, pp. 323-336
-
-
Wei, L.1
Parkinson, J.2
MacDonald, T.M.3
-
13
-
-
34247519400
-
-
http://www.pharmacoepi.org/resources/guidelines_08027.cfm
-
-
-
-
14
-
-
0036720351
-
Adherence to statin treatment and readmission of patients after myocardial infarction: A six year follow up study
-
Wei L, Wang J, Thompson P, et al. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart 2002; 88: 229-233.
-
(2002)
Heart
, vol.88
, pp. 229-233
-
-
Wei, L.1
Wang, J.2
Thompson, P.3
-
15
-
-
34247469554
-
-
http://www.show.scot.nhs.ukrisdonline/Scottish_Health_Statistics/SHS98/ Appendix.pdf
-
-
-
-
16
-
-
0032032592
-
Comparative dose efficacy study of atorvastatin versus sinivastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)
-
Jones P, Kafonek S, Laurora I, Hunninghake D. Comparative dose efficacy study of atorvastatin versus sinivastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am J Cardiol 1998; 81: 582-587.
-
(1998)
Am J Cardiol
, vol.81
, pp. 582-587
-
-
Jones, P.1
Kafonek, S.2
Laurora, I.3
Hunninghake, D.4
-
17
-
-
0038645309
-
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)
-
Jones PH, Davidson MH, Stein EA, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial). Am J Cardiol 2003; 92: 152-160.
-
(2003)
Am J Cardiol
, vol.92
, pp. 152-160
-
-
Jones, P.H.1
Davidson, M.H.2
Stein, E.A.3
-
18
-
-
27744473507
-
Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: A comparison of methods
-
Zhou Z, Rahme E, Abrahamowicz M, Pilote L. Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods. Am J Epidemiol 2005; 162: 1016-1023.
-
(2005)
Am J Epidemiol
, vol.162
, pp. 1016-1023
-
-
Zhou, Z.1
Rahme, E.2
Abrahamowicz, M.3
Pilote, L.4
-
19
-
-
0036804450
-
Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West of Scotland Coronary Prevention Study (WOSCOPS)
-
Streja L, Packard CJ, Shepherd J, Cobbe S, Ford I. Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West of Scotland Coronary Prevention Study (WOSCOPS). Am J Cardiol 2002; 90: 731-736.
-
(2002)
Am J Cardiol
, vol.90
, pp. 731-736
-
-
Streja, L.1
Packard, C.J.2
Shepherd, J.3
Cobbe, S.4
Ford, I.5
-
20
-
-
0018962999
-
Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project
-
The Coronary Drug Project Research Group
-
The Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N Engl J Med 1980; 303: 1038-1041.
-
(1980)
N Engl J Med
, vol.303
, pp. 1038-1041
-
-
-
21
-
-
17244372297
-
Smoking
-
eds, Stationary Office: Edinburgh, Scotland, United Kingdom
-
Turner R. Smoking. In Scotland's Health: Scottish Health Survey 1995, Vol 1, Dong W, Erins B (eds). Stationary Office: Edinburgh, Scotland, United Kingdom, 1997: 140-141.
-
(1995)
Scotland's Health: Scottish Health Survey
, vol.1
, pp. 140-141
-
-
Turner, R.1
-
22
-
-
0033928767
-
Socio-economic status, obesity and prevalence of Type 1 and Type 2 diabetes mellitus
-
Evans JM, Newton RW, Ruta DA, MacDonald TM, Morris AD. Socio-economic status, obesity and prevalence of Type 1 and Type 2 diabetes mellitus. Diabet Med. 2000; 17: 478-480.
-
(2000)
Diabet Med
, vol.17
, pp. 478-480
-
-
Evans, J.M.1
Newton, R.W.2
Ruta, D.A.3
MacDonald, T.M.4
Morris, A.D.5
-
23
-
-
0030716411
-
Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: Cohort study
-
MacDonald TM, Morant SV, Robinson GC, et al. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. BMJ 1997; 315: 1333-1337.
-
(1997)
BMJ
, vol.315
, pp. 1333-1337
-
-
MacDonald, T.M.1
Morant, S.V.2
Robinson, G.C.3
-
24
-
-
11144355354
-
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
-
Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-1505.
-
(2004)
N Engl J Med
, vol.350
, pp. 1495-1505
-
-
Cannon, C.P.1
Braunwald, E.2
McCabe, C.H.3
-
25
-
-
15944410609
-
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
-
LaRosa J, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425-1435.
-
(2005)
N Engl J Med
, vol.352
, pp. 1425-1435
-
-
LaRosa, J.1
Grundy, S.M.2
Waters, D.D.3
-
26
-
-
19644401171
-
Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease
-
Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 2004; 141: 764-770.
-
(2004)
Ann Intern Med
, vol.141
, pp. 764-770
-
-
Wei, L.1
MacDonald, T.M.2
Walker, B.R.3
|